Antegenes introduced real-life innovations for personalized cancer prevention at EXPO 2020 Dubai

Articles
14 February 2022

The theme of World’s Fair Expo Dubai 2020 is “Connecting Minds, Creating the Future”, emphasising how we all have the power to build a better world and shape the future. With this in mind, Antegenes was proud to organize a business seminar, where we discussed how to implement innovative genetic information into cancer precision prevention with the goal to help people live longer and healthier lives.

It was an immense honour to welcome in our panel:
Dr Fatima Alkaabi, the Director of the Genome Office in Abu Dhabi Executive Office (UAE),
Ms Jumana AlAzazi also from the Genome Office (UAE) and
Dr James Mackay, Medical Director of Everything Genetic Ltd (UK).

The panel was moderated by Antegenes CEO & Founder Dr Peeter Padrik.

“Our discussion with Dr Fatima Alkaabi and Dr James Mackay confirmed that United Arab Emirates, United Kingdom and Estonia all have the same visions for genetics-based personalized prevention of cancers and other common diseases, and have already taken the first steps for integrating genomic medicine into healthcare. We acknowledged, that we need collaboration among stakeholders from different countries to support and ensure that the best genetics-based innovative solutions and screening programs are integrated in healthcare systems globally,” said Dr Peeter Padrik after the event.

The business seminar titled “Digital nation. Personalized solutions for healthcare & wellbeing” took place on 31st of January, and was organized by Antegenes and the City of Tartu, both official members of the Estonian Pavilion.

Other panels focused on digital health solutions and changes and challenges in the molecular diagnostics. Companies in the Estonian health-tech delegation taking part of the seminar were Asper Biogene, Competence Centre on Health Technologies, Connected Health Cluster, DocuMental, Institute of Genomics at the University of Tartu, Migrevention, Nordwise Biotech, Solis BioDyne, Tartu Biotechnology Park, and Triumf Health.

As one of the companies of the Estonian health business delegation, Antegenes also met with representatives from the United Arab Emirates (UAE) Ministry of Health and Prevention and the Abu Dhabi Department of Health to discuss opportunities for cooperation. Dr Padrik commented on the opportunities existing between the two countries: “Similar to Estonia, one of the important goals of the health care system in the United Arab Emirates is the personal prevention, diagnosis, and treatment of diseases. A common element definitely shared with Estonia is establishing a nationwide genome project and implementing digital health care opportunities to create a better system.”

Antegenes was supported by Connected Health Cluster and Enterprise Estonia.